COMPANY PROFILE

Gemelli Biotech

Explore full profile

Biotechnology company that specializes in the microbiome, and IBS diagnostics

Raleigh, United StatesFounded 2018Biotech & Life Sciences

Valuation $100–250M Last recorded · 2022

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Gemelli Biotech

Gemelli Biotech is a pioneering company in the field of precision diagnostics for gastrointestinal (GI) diseases. The company focuses on leveraging cutting-edge biological discoveries related to the microbiome to develop non-invasive diagnostic tools. These tools enable clinicians to accurately detect scientifically validated biomarkers and provide optimal treatment for GI conditions such as Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), excess hydrogen sulfide, and post-infectious Irritable Bowel Syndrome (IBS).

Gemelli Biotech primarily serves healthcare providers, including gastroenterologists and general practitioners, who require precise diagnostic solutions to improve patient outcomes. The company operates in the healthcare diagnostics market, which is characterized by a growing demand for non-invasive and accurate diagnostic methods.

The business model of Gemelli Biotech revolves around the development and commercialization of its diagnostic tests. The company generates revenue by selling these diagnostic kits to healthcare providers and laboratories. Additionally, Gemelli Biotech may engage in partnerships with research institutions and pharmaceutical companies to further validate and expand its diagnostic offerings.

Gemelli Biotech's innovative approach not only enhances the accuracy of GI disease diagnosis but also contributes to personalized treatment plans, ultimately improving patient care and reducing healthcare costs.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Raleigh, United States
Employees: 24
Open positions: None listed
Dealroom signal: 71.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Health Diagnostics, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Jun 2022	$19M	$76M	Carolina Angel Network · Blue Ox Healthcare Partners · CerraCap Ventures · Cedars-Sinai	↗
DEBT✓Debt	Mar 2021	$5.5M	—	Undisclosed	—

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Gemelli Biotech website traffic

Latest recorded traffic for Gemelli Biotech is 4.5K monthly website visits, up 25% over the last three months. Gemelli Biotech's team grew 4.3% over the past year.

Latest monthly visits4.5K 3-month web change+25% 1-year team growth+4.3%

Monthly website visitsFeb 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
TATagomicsMultiomic platform for disease biomarker discovery and diagnostics	Cambridge, United Kingdom	Operational	25	$12M	$35M
STSolve TherapeuticsTargeted cancer therapies enhancing safety and precision	San Diego, United States	Operational
EOEpi OneDeveloping a groundbreaking cancer diagnosis platform for early detection, prognosis, and post-diagnosis drug response prediction	New York City, United States	Operational
NRNucleus RadioPharmaTransforming lives with radiopharmaceuticals by leveraging world class clinical, development, manufacturing, and supply chain expertise	Davidson, United States	Operational
YTYsotope TheranosticsTargeted radiopharmaceuticals for precision oncology	Madrid, Spain	Operational
BIBiotomeDeveloping high-precision antibody diagnostics	City of Nedlands, Australia	Operational
RORadionetics OncologyRadionetics Oncology is a precision oncology company focusing on the discovery and development of radiopharmaceuticals	San Diego, United States	Operational
ASAtley SolutionsAutomated, standardised and reproducible production of At-211 radiopharmaceuticals for targeted alpha therapy	Göteborgs Stad, Sweden	Operational